Join
Live feed
·
INSIDERFilingvia Quantisnow
Bicara Therapeutics Inc. logo

Director Mazumdar-Shaw Kiran converted options into 6,165,428 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BCAX· Bicara Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCAX (Bicara Therapeutics Inc.) and more on Quantisnow.